1. 2024
  2. Atranorin is a novel potential candidate drug for treating myelodysplastic syndrome

    Semenov, K. N., Prokopiev, I. A., Petukhova, N. V., Kremenetskaya, U. A., Senichkina, D. A., Epifanovskaya, O. S., Rumiantsev, A. M., Andoskin, P. A., Rizaev, J. A., Kholmurodova, D. K., Ageev, S. V., Anufrikov, Y. A., Zakharov, E. E., Moiseev, I. S. & Sharoyko, V. V., 1 Nov 2024, In: Journal of Molecular Liquids. 413, 16 p., 125743.

    Research output: Contribution to journal › Article › peer-review

ID: 84752226